Water Proton NMR: A Tool for Protein Aggregation Characterization

被引:40
作者
Taraban, Marc B. [1 ]
DePaz, Roberto A. [2 ]
Lobo, Brian [2 ]
Yu, Y. Bruce [1 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] MedImmune, Formulat Sci, One MedImmune Way, Gaithersburg, MD 20878 USA
关键词
THERAPEUTIC PROTEIN; MONOCLONAL-ANTIBODIES; STABILITY; FORMULATIONS; RELAXATION; PARTICLES; SUSPENSIONS; PRODUCTS;
D O I
10.1021/acs.analchem.7b00464
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Formulation stability is a critical attribute of any protein-based biopharmaceutical drug due to a protein's inherent tendency to - aggregate. Advanced analytical techniques currently used for characterization of protein aggregates are prone to a number of limitations and usually require additional manipulations with the sample, such as dilution, separation, labeling, and use of special cuvettes. In the present work, we compared conventional techniques for the analysis of protein aggregates with a novel approach that employs the water proton transverse relaxation rate R-2((H2O)-H-1). We explored differences in the sensitivity of conventional techniques, size-exclusion chromatography (SEC), microflow imaging (MFI), and dynamic light scattering (DLS), and water NMR (wNMR) toward the presence of monoclonal antibody aggregates generated by different stresses. We demonstrate that wNMR outperformed SEC, DLS, and MFI in that it was most consistently sensitive to increases in both soluble and insoluble aggregates, including subvisible particles. The simplicity of wNMR, its sensitivity, and possibility of noninvasive measurements are unique advantages that would permit its application for more efficient and higher throughput optimization of protein formulations.
引用
收藏
页码:5494 / 5502
页数:9
相关论文
共 37 条
[1]  
Arakawa T., 2007, Bioproc Int, V5, P36
[2]   Subvisible Particle Counting Provides a Sensitive Method of Detecting and Quantifying Aggregation of Monoclonal Antibody Caused by Freeze-Thawing: Insights Into the Roles of Particles in the Protein Aggregation Pathway [J].
Barnard, James G. ;
Singh, Satish ;
Randolph, Theodore W. ;
Carpenter, John F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (02) :492-503
[3]  
Berne BJ, 2000, DYNAMIC LIGHT SCATTE
[4]   Potential Inaccurate Quantitation and Sizing of Protein Aggregates by Size Exclusion Chromatography: Essential Need to Use Orthogonal Methods to Assure the Quality of Therapeutic Protein Products [J].
Carpenter, John F. ;
Randolph, Theodore W. ;
Jiskoot, Wim ;
Crommelin, Daan J. A. ;
Middaugh, C. Russell ;
Winter, Gerhard .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (05) :2200-2208
[5]   Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality [J].
Carpenter, John F. ;
Randolph, Theodore W. ;
Jiskoot, Wim ;
Crommelin, Daan J. A. ;
Middaugh, C. Russell ;
Winter, Gerhard ;
Fan, Ying-Xin ;
Kirshner, Susan ;
Verthelyi, Daniela ;
Kozlowski, Steven ;
Clouse, Kathleen A. ;
Swann, Patrick G. ;
Rosenberg, Amy ;
Cherney, Barry .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (04) :1201-1205
[6]  
Chu B., 1996, LASER LIGHT SCATTERI
[7]   New and Evolving Techniques for the Characterization of Peptide Therapeutics [J].
D'Addio, Suzanne M. ;
Bothe, Jameson R. ;
Neri, Claudia ;
Walsh, Paul L. ;
Zhang, Jingtao ;
Pierson, Elizabeth ;
Mao, Yun ;
Gindy, Marian ;
Leone, Anthony ;
Templeton, Allen C. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (10) :2989-3006
[8]  
Fabelinskii I. L., 1968, Molecular Scattering of Light
[9]   The Effect of Small Oligomeric Protein Aggregates on the Immunogenicity of Intravenous and Subcutaneous Administered Antibodies [J].
Fathallah, Anas M. ;
Chiang, Manting ;
Mishra, Anshul ;
Kumar, Sandeep ;
Xue, Li ;
Middaugh, Russell ;
Balu-Iyer, Sathy V. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (11) :3691-3702
[10]   Water proton NMR-a sensitive probe for solute association [J].
Feng, Yue ;
Taraban, Marc B. ;
Yu, Yihua Bruce .
CHEMICAL COMMUNICATIONS, 2015, 51 (31) :6804-6807